Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
Background/AimsInfliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sustai...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Gastroenterology Council for Gut and Liver
2019-09-01
|
| Serie: | Gut and Liver |
| Soggetti: | |
| Accesso online: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl18129 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|